This is a non-material marketing campaign with no disclosed financial impact. No immediate trading catalyst.
EBS drugs
EBS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 29 $7.99entry
- T+1 · 7mo ago +3.00%α +1.98% · $8.23
- T+5 · 7mo ago +13.89%α +10.78% · $9.10
- T+20 · 6mo ago +14.89%α +8.85% · $9.18
- T+60 · 4mo ago −9.14%α −13.25% · $7.26
Price Chart
How similar events traded
Executive Summary
Emergent BioSolutions announced a partnership with baseball player Davis Schneider to promote awareness of NARCAN Nasal Spray for opioid overdose reversal. The campaign includes an interactive Opioid Crisis Impact Map and aims to reduce stigma. No financial terms were disclosed.
Key Facts
- Partnership with Toronto Blue Jays' Davis Schneider to promote NARCAN Nasal Spray
- Schneider shares his personal story of losing his brother to opioid overdose on Emergent's Opioid Crisis Impact Map
- More than 100 million doses of NARCAN Nasal Spray delivered since 2018
- NARCAN Nasal Spray available at no cost in several Canadian provinces and territories
Financial Impact
No financial terms disclosed; campaign is primarily educational and awareness-focused.
Risk Factors
- No discernible risk from this announcement
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3283594 |
Track record
23 reports on EBS
4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +14.89% at T+20 after the Apr 29, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $5.76 Now $5.81 +0.96% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.75 Now $5.81 +1.13% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.79 Now $5.81 +0.35% settles Nov 23
- Nov 4, 202612d ago 8-K Neutral 4/10 Entry $5.85 to $5.89 Now $5.81 −0.68% ▲ +0.68% −2.61% vs SPY
- Nov 2, 202614d ago 8-K Bearish 6/10 Entry $6.25 to $6.05 Now $5.81 +7.04% ▲ +3.20% +2.61% vs SPY
- Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $6.81 to $6.06 Now $5.81 −14.68% ▼ −11.01% −8.31% vs SPY
- Oct 16, 20264w ago 8-K Neutral 3/10 Entry $6.38 to $6.23 Now $5.81 −8.93% ▼ −2.35% −2.44% vs SPY
- Oct 7, 20265w ago 144 Neutral 2/10 Entry $6.81 to $7.18 Now $5.81 −14.68% ▲ +5.43% +5.71% vs SPY
- Jun 29, 202620w ago 8-K Bullish 5/10 Entry $8.46 to $8.18 Now $5.81 −31.32% ▼ −3.31% −4.70% vs SPY
- Jun 4, 202623w ago Press Release Neutral 2/10 Entry $8.44 to $8.39 Now $5.81 −31.16% ▼ −0.59% +1.96% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers